A study, published in the Journal of Vascular and Interventional Radiology suggests that percutaneous image-guided irreversible electroporation of unresectable locally advanced pancreatic adenocarcinoma is associated with a satisfactory safety profile.
Teleflex has announced that its Arrow VPS Rhythm device with optional TipTracker technology has been issued 510(k) clearance so that the device can be commercialised in the USA.
Abbott announced on 4 January 2017 that it has completed the acquisition of St Jude Medical.
NICE’s Scientific Advice programme will work with companies looking to attain both FDA approval and payer coverage. The UK’s National Institute for Health and Care Excellence (NICE) has announced its participation in the US Food and Drug Administration (FDA)’s Payer Communication Taskforce. This programme aims to accelerate US patient access to new technologies by gathering evidence of clinical effectiveness in an attempt to encourage US insurers to fund new treatments, post FDA-approval.
BTG International Canada has announced the commercial launch of DC Bead Lumi in Canada. The launch represents the first market commercialisation of DC Bead Lumi in the world, with regulatory clearances and launches planned for additional markets worldwide.
Sirtex has announced that SIR-Spheres Y-90 resin microspheres have been included as a Category 2A recommended treatment in the latest National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for colon cancer and rectal cancer. This designation denotes that there is uniform consensus among the NCCN panel that selective internal radiation therapy (SIRT) with yttrium-90 microspheres is an appropriate option in patients with liver dominant, chemotherapy resistant colorectal disease. This recommendation places SIR-Spheres Y-90 resin microspheres at the same designation as the recommended mCRC systemic chemotherapeutic regimens.
WCIO has announced via email communication that the board of directors of the organisation, a non-profit association that supports and promotes the field of interventional oncology (IO), has established the Society of Interventional Oncology (SIO), effective 17 January. The society’s annual IO conference will maintain its name of WCIO.
Ask4UFE has announced the #LoveYourUterus campaign to encourage women with painful fibroids to share their stories of health and healing. Uterine fibroids often result in women having hysterectomies because they are unaware of uterine fibroid embolization (UFE), which is a less invasive procedure.
Oxygen therapy, Granulox (inFirst Healthcare), has been shown to be an effective, safe and easy-to-use treatment, according to a new study published in the recent edition of Diabetic Foot and Ankle Journal.
Modulated Imaging has received clearance from the US Food and Drug Administration (FDA) for its Ox-Imager CS technology. This device is designed to assist clinicians with the identification of lower limb vascular issues, so that patients can receive appropriate, timely treatment.
Endologix has resumed shipments of all sizes of AFX2 endovascular abdominal aortic aneurysm systems. The large diameter sizes of AFX2 were placed on a temporary hold on 27 December, 2016, to investigate a manufacturing issue. Since the hold, the company has been working on process improvements and developed additional testing protocols that have been reviewed by US Food and Drug Administration (FDA). Shipments of the larger sizes of AFX2 resumed on 17 January.
Intact Vascular has attained the CE mark for the Tack endovascular system for the repair of arterial dissections following percutaneous transluminal angioplasty (PTA) below the knee. This extended indication in the European Union enables the use of the Tack system in the tibial arteries between the knee and ankle.
Updated European Society for Vascular Surgery (ESVS) clinical practice guidelines regarding the management of diseases of the descending thoracic aorta have been published in the European Journal of Vascular and Endovascular Surgery.
Due to its two-dimensional (2D) nature and the high radiation exposure associated with its use, fluoroscopy is an imperfect solution to endovascular surgery’s need for intraoperative imaging. At the 2016 VEITHsymposium (15–19 November, New York, USA), Matthew Eagleton, Cleveland Clinic, Cleveland, USA, presented his centre’s initial experiences with the Intraoperative Positioning System (IOPS; Centerline Biomedical), suggesting that it may represent an opportunity to transition away from fluoroscopy.
The Society for Vascular Surgery (SVS) and the Society for Vascular Nursing (SVN) have issued a statement encouraging vascular surgery teams to actively assist smokers with smoking cessation before surgery.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos